Velarion Records
Free. Unsubscribe any time.

Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics, Inc. filed 4 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 4 transactions and 17,613 shares. 2 carry the SEC's AFF10B5ONE flag; 2 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Xilio Therapeutics, Inc. 4

Adoption dates in Xilio Therapeutics, Inc. 1

Results prints in Xilio Therapeutics, Inc. 0

Trades before a print in Xilio Therapeutics, Inc. 0

Interval to Xilio Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Xilio Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on April 8, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.